Peter Saunders
Director/Board Member at Asterion Bio Med, Inc.
Profile
Peter Saunders is the founder of Oryx Pharmaceuticals, Inc. He is currently a Director at Asterion Bio Med, Inc. He was formerly a Director & Director-International Business Affairs at Optima Medical Innovations Corp.
from 2018 to 2020.
He was also a Vice President-Sales at Wayland Group Corp.
Peter Saunders active positions
| Companies | Position | Start |
|---|---|---|
Asterion Bio Med, Inc.
 Asterion Bio Med, Inc. Medical/Nursing ServicesHealth Services Asterion Bio Med, Inc. provides healthcare services. The firm is a consolidation platform for hospital and independent healthcare facilities. The company was founded on May 02, 2017 and is headquartered in Toronto, Canada. | Director/Board Member | - |
Former positions of Peter Saunders
| Companies | Position | End |
|---|---|---|
| OPTIMA MEDICAL INNOVATIONS CORP. | Director/Board Member | 19/07/2020 |
| WAYLAND GROUP CORP. | Sales & Marketing | 12/02/2018 |
Oryx Pharmaceuticals, Inc.
 Oryx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Oryx Pharmaceuticals, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Mississauga, Canada. Oryx Pharmaceuticals was acquired by Sumitomo Pharma America, Inc., part of Sumitomo Chemical Co., Ltd. from October 20, 2009 on June 03, 2008 for $70 million. The company was founded by Peter Saunders. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| WAYLAND GROUP CORP. | Process Industries |
| OPTIMA MEDICAL INNOVATIONS CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Oryx Pharmaceuticals, Inc.
Oryx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Oryx Pharmaceuticals, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Mississauga, Canada. Oryx Pharmaceuticals was acquired by Sumitomo Pharma America, Inc., part of Sumitomo Chemical Co., Ltd. from October 20, 2009 on June 03, 2008 for $70 million. The company was founded by Peter Saunders. | Health Technology |
Asterion Bio Med, Inc.
Asterion Bio Med, Inc. Medical/Nursing ServicesHealth Services Asterion Bio Med, Inc. provides healthcare services. The firm is a consolidation platform for hospital and independent healthcare facilities. The company was founded on May 02, 2017 and is headquartered in Toronto, Canada. | Health Services |
- Stock Market
- Insiders
- Peter Saunders
